These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15196814

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
    Roth MD, Whittaker KM, Choi R, Tashkin DP, Baldwin GC.
    J Leukoc Biol; 2005 Dec; 78(6):1198-203. PubMed ID: 16204638
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.
    Touraine JL, Sanhadji K, Sembeil R.
    Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A, Tanaka R, Kodama A, Yamamoto N, Ansari AA, Tanaka Y.
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis.
    McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, Peault B, Rabin L, Shih CC, Yee E, Lieberman M.
    Annu Rev Immunol; 1991 Dec; 9():399-429. PubMed ID: 1910684
    [Abstract] [Full Text] [Related]

  • 31. Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.
    Stevens M, Pollicita M, Pannecouque C, Verbeken E, Tabarrini O, Cecchetti V, Aquaro S, Perno CF, Fravolini A, De Clercq E, Schols D, Balzarini J.
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1407-13. PubMed ID: 17242146
    [Abstract] [Full Text] [Related]

  • 32. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse.
    Kaneshima H, Shih CC, Namikawa R, Rabin L, Outzen H, Machado SG, McCune JM.
    Proc Natl Acad Sci U S A; 1991 May 15; 88(10):4523-7. PubMed ID: 1903543
    [Abstract] [Full Text] [Related]

  • 33. Suppression of HIV infection in AZT-treated SCID-hu mice.
    McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H.
    Science; 1990 Feb 02; 247(4942):564-6. PubMed ID: 2300816
    [Abstract] [Full Text] [Related]

  • 34. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
    Vanwolleghem T, Meuleman P, Libbrecht L, Roskams T, De Vos R, Leroux-Roels G.
    Gastroenterology; 2007 Oct 02; 133(4):1144-55. PubMed ID: 17919490
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection.
    Alder J, Hui YH, Clement J.
    Antiviral Res; 1995 May 02; 27(1-2):85-97. PubMed ID: 7486961
    [Abstract] [Full Text] [Related]

  • 36. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 02; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 37. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF, Torbett BE.
    Gene Ther; 2006 Oct 02; 13(20):1480-92. PubMed ID: 16738691
    [Abstract] [Full Text] [Related]

  • 38. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE, Zaccaro L, Tomei PE.
    J Ethnopharmacol; 2005 Apr 26; 98(3):323-7. PubMed ID: 15814267
    [Abstract] [Full Text] [Related]

  • 39. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi NC, Anderson KC.
    Clin Cancer Res; 2005 Jun 01; 11(11):4251-8. PubMed ID: 15930364
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.